Mario A. Calvo

Valdivia, LR, Chile

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

The Natural Killer Cell Landscape in the Natural History of Hantavirus Cardiopulmonary Syndrome in a Chilean Cohort.

The Natural Killer Cell Landscape in the Natural History of Hantavirus Cardiopulmonary Syndrome in a Chilean Cohort.

Journal: Viruses
Published: May 28, 2026

Hantavirus infection: A narrative review focusing on epidemiology, diagnosis, infection control and treatment in the era of globalisation.

Hantavirus infection: A narrative review focusing on epidemiology, diagnosis, infection control and treatment in the era of globalisation.

Journal: Medicina intensiva
Published: May 13, 2026

Polyfunctional antibody signature defines protection in Andes hantavirus survival.

Polyfunctional antibody signature defines protection in Andes hantavirus survival.

Journal: Frontiers in immunology
Published: October 23, 2025

Longitudinal immune profiling uncovers regulatory T cell signatures associated with the progression of COVID-19.

Longitudinal immune profiling uncovers regulatory T cell signatures associated with the progression of COVID-19.

Journal: Frontiers in immunology
Published: September 02, 2025

Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial.

Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial.

Journal: Nature communications
Published: January 27, 2025

Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progression.

Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progression.

Journal: eLife
Published: October 29, 2024

Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Population Aged 3 Years and Older in Chile and the Philippines: A Phase 3, Non-Inferiority, Double-Blind, Randomized Controlled Clinical Trial.

Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Population Aged 3 Years and Older in Chile and the Philippines: A Phase 3, Non-Inferiority, Double-Blind, Randomized Controlled Clinical Trial.

Journal: Vaccines
Published: June 21, 2024

A prospective, multicenter study of invasive fungal disease caused by molds in children and adults in Chile.

A prospective, multicenter study of invasive fungal disease caused by molds in children and adults in Chile.

Journal: PloS one
Published: June 17, 2024

Viral shedding and viraemia of Andes virus during acute hantavirus infection: a prospective study.

Viral shedding and viraemia of Andes virus during acute hantavirus infection: a prospective study.

Journal: The Lancet. Infectious diseases
Published: November 29, 2023

Opinions, Attitudes and Factors Related to SARS-CoV-2 Vaccine Uptake in Eight South American Countries.

Opinions, Attitudes and Factors Related to SARS-CoV-2 Vaccine Uptake in Eight South American Countries.

Journal: Vaccines
Published: September 01, 2023

Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile.

Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile.

Journal: Vaccines
Published: June 06, 2023

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.

Journal: mBio
Published: November 16, 2022
Showing 1-12 of 37

Last Updated: 09/26/2026